- Home
- IOVA vs IVT Comparison
IOVA vs IVT Comparison
Compare IOVA & IVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- IVT
- Stock Information
- Founded
- IOVA 2007
- IVT 2005
- Country
- IOVA United States
- IVT United States
- Employees
- IOVA N/A
- IVT N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- IVT Real Estate Investment Trusts
- Sector
- IOVA Health Care
- IVT Real Estate
- Exchange
- IOVA Nasdaq
- IVT Nasdaq
- Market Cap
- IOVA 2.6B
- IVT 2.2B
- IPO Year
- IOVA N/A
- IVT N/A
- Fundamental
- Price
- IOVA $5.82
- IVT $29.55
- Analyst Decision
- IOVA Strong Buy
- IVT Buy
- Analyst Count
- IOVA 9
- IVT 4
- Target Price
- IOVA $23.06
- IVT $31.75
- AVG Volume (30 Days)
- IOVA 7.2M
- IVT 390.2K
- Earning Date
- IOVA 02-26-2025
- IVT 02-11-2025
- Dividend Yield
- IOVA N/A
- IVT 3.03%
- EPS Growth
- IOVA N/A
- IVT 143.52
- EPS
- IOVA N/A
- IVT 0.19
- Revenue
- IOVA $90,858,000.00
- IVT $273,974,000.00
- Revenue This Year
- IOVA $13,803.28
- IVT N/A
- Revenue Next Year
- IOVA $167.55
- IVT $7.37
- P/E Ratio
- IOVA N/A
- IVT $157.42
- Revenue Growth
- IOVA 12751.20
- IVT 6.14
- 52 Week Low
- IOVA $5.05
- IVT $23.53
- 52 Week High
- IOVA $18.33
- IVT $31.65
- Technical
- Relative Strength Index (RSI)
- IOVA 49.38
- IVT 49.13
- Support Level
- IOVA $5.44
- IVT $29.41
- Resistance Level
- IOVA $5.80
- IVT $31.01
- Average True Range (ATR)
- IOVA 0.31
- IVT 0.63
- MACD
- IOVA 0.09
- IVT -0.01
- Stochastic Oscillator
- IOVA 82.43
- IVT 40.64
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.